Iolyx Therapeutics
About Iolyx Therapeutics
This clinical-stage company develops targeted formulations for the treatment of ocular inflammation, utilizing a platform that integrates immunology and ophthalmology for precise tissue delivery. By addressing inflammation at its source in both the anterior and posterior segments of the eye, the company enhances treatment efficacy and safety for patients with ocular diseases.
What does Iolyx Therapeutics do?
This clinical-stage company develops targeted formulations for the treatment of ocular inflammation, utilizing a platform that integrates immunology and ophthalmology for precise tissue delivery. By addressing inflammation at its source in both the anterior and posterior segments of the eye, the company enhances treatment efficacy and safety for patients with ocular diseases.
Where is Iolyx Therapeutics located?
Iolyx Therapeutics is based in Burlingame, United States.
How much funding has Iolyx Therapeutics raised?
Iolyx Therapeutics has raised 30000000.
- Location
- Burlingame, United States
- Funding
- 30000000
- Employees
- 11 employees
- Major Investors
- Alumni Ventures